Caricamento...
Homing in on the hepatic scar: recent advances in cell-specific targeting of liver fibrosis
Despite the high prevalence of liver disease globally, there are currently no approved anti-fibrotic therapies to treat patients with liver fibrosis. A major goal in anti-fibrotic therapy is the development of drug delivery systems that allow direct targeting of the major pro-scarring cell populatio...
Salvato in:
| Pubblicato in: | F1000Res |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
F1000Research
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955024/ https://ncbi.nlm.nih.gov/pubmed/27508067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.8822.1 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|